Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy.

Diagnostics (Basel) · 2025 · PMC12731878 · PMID 41464158

Europe PMC DOI

hedged sentence

0.3110

closest p · 6.2× alpha

0.3110

boldest claim

The sentences

did not reach statistical significancep = 0.311not close (p > 0.1)

Although the clinical stage appeared to be associated with a trend toward reduced PFS as the disease progressed, this variation did not reach statistical significance (median PFS: stage II, 40.8 months; stage III, not reached; stage IVA, 19.8 months; p = 0.311).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.